Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics
出版年份 2017 全文链接
标题
Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics
作者
关键词
-
出版物
Pigment Cell & Melanoma Research
Volume 31, Issue 2, Pages 253-266
出版商
Wiley
发表日期
2017-10-03
DOI
10.1111/pcmr.12650
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibitors of cyclin-dependent kinases as cancer therapeutics
- (2017) Steven R. Whittaker et al. PHARMACOLOGY & THERAPEUTICS
- BRAFmutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions
- (2016) Ann-Cathrine Larsen et al. ACTA OPHTHALMOLOGICA
- Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing
- (2016) Beryl Royer-Bertrand et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Metastatic disease from uveal melanoma: treatment options and future prospects
- (2016) Richard D Carvajal et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- The hVps34‐SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth
- (2016) Ruzica Bago et al. EMBO JOURNAL
- Selumetinib for the treatment of metastatic uveal melanoma: past and future perspectives
- (2016) Kimberly M Komatsubara et al. Future Oncology
- Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
- (2016) Fabrice Barlesi et al. LANCET
- Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor
- (2016) J. Van den Bossche et al. MEDICINAL RESEARCH REVIEWS
- Molecular profiling of single circulating tumor cells from lung cancer patients
- (2016) Seung-min Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
- (2016) Guillaume Carita et al. Oncotarget
- BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
- (2016) Zhenfeng Zhang et al. Theranostics
- Management of Primary Acquired Melanosis, Nevus, and Conjunctival Melanoma
- (2016) Andrew Kao et al. Cancer Control
- Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
- (2016) Alison M. Kurimchak et al. Cell Reports
- Driver Mutations in Uveal Melanoma
- (2016) Christina L. Decatur et al. JAMA Ophthalmology
- B-Raf inhibition in conjunctival melanoma cell lines with PLX 4720
- (2015) Aline I Riechardt et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation
- (2015) Tetsuo Mashima et al. CANCER SCIENCE
- Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer
- (2015) R. Ferrarotto et al. CLINICAL CANCER RESEARCH
- BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population
- (2015) Ismail Yilmaz et al. Indian Journal of Pathology and Microbiology
- BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
- (2015) Grazia Ambrosini et al. Oncotarget
- BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
- (2015) Emma K Baker et al. Scientific Reports
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- Association BetweenNRASandBRAFMutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
- (2015) Nancy E. Thomas et al. JAMA Oncology
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
- (2014) B T Gjertsen et al. LEUKEMIA
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- AnimalTFDB 2.0: a resource for expression, prediction and functional study of animal transcription factors
- (2014) Hong-Mei Zhang et al. NUCLEIC ACIDS RESEARCH
- Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
- (2013) Z. Cheng et al. CLINICAL CANCER RESEARCH
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Evidence of epidermal growth factor receptor expression in uveal melanoma: Inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity
- (2013) Adriana Amaro et al. EUROPEAN JOURNAL OF CANCER
- Master regulators of FGFR2 signalling and breast cancer risk
- (2013) Michael N. C. Fletcher et al. Nature Communications
- BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
- (2012) C. J. Ott et al. BLOOD
- A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas – a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network
- (2012) K Mross et al. BRITISH JOURNAL OF CANCER
- Small-Molecule Inhibition of BRDT for Male Contraception
- (2012) Martin M. Matzuk et al. CELL
- The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism
- (2012) X. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Genetic and molecular characterization of uveal melanoma cell lines
- (2012) K. G. Griewank et al. Pigment Cell & Melanoma Research
- Role of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2
- (2012) Dongsheng Yan et al. PLoS One
- FoxM1: A Master Regulator of Tumor Metastasis
- (2011) P. Raychaudhuri et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- A Comparative Transcriptomic Analysis of Uveal Melanoma and Normal Uveal Melanocyte
- (2011) Jianhong An et al. PLoS One
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estimating prognosis for survival after treatment of choroidal melanoma
- (2011) Bertil Damato et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1
- (2010) Mónica Alvarez-Fernández et al. EMBO REPORTS
- Phase I and Pharmacologic Study of SNS-032, a Potent and Selective Cdk2, 7, and 9 Inhibitor, in Patients With Advanced Chronic Lymphocytic Leukemia and Multiple Myeloma
- (2010) Wei-Gang Tong et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity
- (2009) D. Rudolph et al. CLINICAL CANCER RESEARCH
- Discovery and Exploitation of Inhibitor-resistant Aurora and Polo Kinase Mutants for the Analysis of Mitotic Networks
- (2009) Paul J. Scutt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of Aurora B Expression by the Bromodomain Protein Brd4
- (2009) J. You et al. MOLECULAR AND CELLULAR BIOLOGY
- Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
- (2009) Anup Dey et al. MOLECULAR BIOLOGY OF THE CELL
- Anaphase-Promoting Complex/Cyclosome-Cdh1-Mediated Proteolysis of the Forkhead Box M1 Transcription Factor Is Critical for Regulated Entry into S Phase
- (2008) H. J. Park et al. MOLECULAR AND CELLULAR BIOLOGY
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
- What is principal component analysis?
- (2008) Markus Ringnér NATURE BIOTECHNOLOGY
- Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression
- (2008) Zheng Fu et al. NATURE CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started